Preparation of Dichlorofluoroethane
Dichlorofluoroethane (HCFC-141b, 1,1-dichloro-1-fluoroethane) is an organic solvent and an important amethylating agent.
Nov 5，2019 Catalyst and Auxiliary
Preparation of 2-Chloro-4-cyanopyridine
2-Chloro-4-cyanopyridine is an important organic intermediate to synthetize substituted pyridines.
Nov 5，2019 Pyridine Compound
Preparation of 3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid
3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid can be used in drug synthesis as an intermediate.
Nov 5，2019 Pharmaceutical intermediates
Preparation of 4,4-Difluoropiperidine hydrochloride
4,4-Difluoropiperidine hydrochloride is a heterocyclic fluorinated building block.
Nov 5，2019 Pyridine Compound
Preparation of 4-fluoro-2-Methoxy-5-Nitroaniline
4-fluoro-2-Methoxy-5-nitroaniline is an important organic intermediate to synthetize substituted benzene products.
Nov 5，2019 Pharmaceutical intermediates
Lithium Aluminum Deuteride: Application in Synthetic Works
lithium aluminum deuteride is used as a reducing agent in organic synthesis, especially for the reduction of esters, carboxylic acids, and amides.
Nov 4，2019 Chemical Reagents
Preparation of Phosphoric acid tris(2-chloro-1-methylethyl) ester
Phosphoric acid tris(2-chloro-1-methylethyl) ester is a flame retardant of low hydrolytic stability, used in polyurethane (PU) rigid and flexible foam, PVC, EVA and phenolics and epoxy resin.
Nov 4，2019 Inorganic acid Esters
Electronic and Optical Properties of Mercuric Iodate
Mercury(II) iodate(V) is dimorphous and crystallizes in two polymorphs named α- and β-Hg(IO3)2. The α-modification was prepared by precipitation of a slightly acidified Hg(NO3)2 solution with an exces
Nov 4，2019 Metal halide and Halogen salt
Applications of Fmoc-Lys(IVDDE)-OH
Fmoc-Lys(IVDDE)-OH is orthogonally protected lysine. The Ddiv protection is stable to piperidine.
Nov 4，2019 Amino Acids and Proteins
Uses and Side effects of Abemaciclib
Abemaciclib (trade names Verzenio and Verzenios) is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 a
Nov 4，2019 API